Concepedia

MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A

Ester Ruiz‐Romeu, Marta Ferrán, A.M. Giménez-Arnau, Beata Bugara, Barbara Lipert, Jolanta Jura, Edwin F. Florencia, Errol P. Prens, Antonio Celada, Ramón M. Pujol,

Journal of Investigative Dermatology · 2016 · 46 citations · 42 references

DOIFull text

Open access

Concepts

References

42

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

Leslie van der Fits, Sabine Mourits, Jane S.A. Voerman et al. · The Journal of Immunology · 2009 · 2.1K citations · Full text

, , +17

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

, , +14

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

Craig L. Leonardi, Robert Matheson, Claus Zachariae et al. · New England Journal of Medicine · 2012 · 930 citations · Full text

, , +17

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

Kim Papp, Craig L. Leonardi, Alan Menter et al. · New England Journal of Medicine · 2012 · 929 citations

, , +17

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways

Kristine Nograles, Lisa C. Zaba, Emma Guttman‐Yassky et al. · British Journal of Dermatology · 2008 · 799 citations · Full text

, , +17